Newsletters
Since I’ve noticed that many newsletters end up in the recipient’s SPAM folder, I’ve created this page as a precaution where all newsletters will be published.
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 225Ac abiraterone abiraterone acetate ADC ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T CD3 clinical trial crispr darolutamide docetaxel drug repurposing drug resistance enzalutamide HRR immunotherapy mcrpc metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer oncolytic virus PARP1 PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data STEAP1 T-cell therapy
Latest Posts
- A-DREAM Trial Suggests Some Men with Metastatic Prostate Cancer May Stop Therapy Safely for a Time May 22, 2026
- Phase 2 TALENT Trial: Talazoparib as Monotherapy or With Enzalutamide in HRR-deficient mCRPC May 22, 2026
- ABBV-969 in mCRPC: Dual‑Targeting ADC Shows Robust PSA and Objective Responses in Heavily Pretreated Patients May 22, 2026
- CONVERGE-01: CONV01-α Shows Activity After Lu-PSMA in mCRPC May 22, 2026
Newsletter 20/2026
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hello fellow warriors! As you can probably tell, every now and then I blow off steam by generating images with AI! This week we have quite a few updates on the clinical trial front, as well as some interesting insights from preclinical […]
Newsletter 19/2026
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hello fellow warriors! This week’s newsletter is a bit lighter than usual, partly because it’s becoming increasingly difficult to find detailed information on new clinical trials. The trials are there, but the mechanisms behind the proposed drugs are often hard to identify. […]
Newsletter 18/2026
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hello fellow warriors! This week I selected the studies I’ll be following during the ASCO 2026 annual meeting, which will take place at the end of the month. There are some very interesting things! But for now, let’s start with this week’s […]